Prognostic factors for outcomes in allogeneic transplantation for CML in the imatinib era: a CIBMTR analysis.

Prognostic factors for outcomes in allogeneic transplantation for CML in the imatinib era: a CIBMTR analysis. Bone Marrow Transplant. 2012 Jun; 47(6):810-6.

View in: PubMed

subject areas

Adolescent
Adult
Aged
Benzamides
Child
Disease-Free Survival
Female
Hematopoietic Stem Cell Transplantation
Humans
Imatinib Mesylate
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Male
Middle Aged
Piperazines
Protein Kinase Inhibitors
Pyrimidines
Retrospective Studies
Siblings
Survival Rate
Transplantation Conditioning
Transplantation, Homologous

authors with profiles

JORGE E CORTES